This website uses own and third-party cookies to enhance the user's experience.
By clicking "Accept" on this banner or using our site, you consent to the use of cookies.
For settings and more information about cookies, view our
Terms and Cookie Policy.
Events & conferences in the Life Sciences industry
Below you find a list of upcoming events in the Life Sciences industry.
We will be attending all events which are flagged with the Biotechgate / Venture Valuation logo.
If you are participating the conference and want to learn more,
please contact us to schedule a meeting.
Life Science Innovation Northwest (LSINW) is the can’t-miss gathering for the PNW life science community. Nowhere else will you find CEOs, investors, research institutions, global health leaders, entrepreneurs, and public and private life science organizations connecting at this scale. With high-impact programming, elevated networking, and dedicated time to meet strategic partners, collaborators, and investors, LSINW 2026 is designed to help attendees build meaningful relationships that move ideas and companies forward.
Germany's largest biotech event, the German Biotech Days 2026 (Deutsche Biotechnologietage, DBT), will take place on April 21 and 22 in Leipzig. The event is the national forum for the German biotechnology industry. The DBT brings together entrepreneurs with scientists and partners from politics, funding institutions and administration. The two-day program highlights the diverse fields of application and the potential of biotechnology, from health research to the bioeconomy.
Representatives from Venture Valuation and Biotechgate will participate in German Biotech Days
Engage with the largest network of potential partners to accelerate your cross-border strategies and expand your reach into the China market.
ChinaBio® Partnering Forum is the largest and most productive life science partnering event in China. To be held as a 2 days in-person, 2 days virtually, April 28–29, 2026, and May 6–7, 2026, the conference will bring together biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for four days of successful partnering.
ChinaBio® Partnering Forum 2025 attracted 700+ delegates from over 500 companies and 30 countries, making it a must-attend global event for companies interested in developing cross-border partnerships, both inside and outside of China. The 2026 edition promises to be even better, with top notch attendance from pharma and biotech companies and investors, as well as leading executives from China's fast-growing life sciences hubs and researchers from China's top universities and institutes.
Representatives from Venture Valuation and Biotechgate will participate in ChinaBio® Partnering Forum
The Pharma Partnering Summit specializes in organizing premier Business Development and Licensing Conferences for Senior Executives and Decision-makers in the life sciences industry. These events provide a platform to discover products and partners while exploring potential partnering opportunities that empower the development and commercialization of drugs, as well as advancing the pharma and biotech sectors in general.
Get 15% off registration with the code MP-15%
Representatives from Venture Valuation and Biotechgate will participate in Pharma Partnering US Summit 2026
Since 2021, the Swiss Biotech Day has seen remarkable growth every year and has become a premier global biotechnology conference for life sciences professionals, fostering international collaboration and impactful partnerships. In 2025 it attracted more than 3,000 participants from 49 countries, including 25 international delegations. It was by far the biggest and most international edition of the Swiss Biotech Day ever.
Join the Swiss Biotech Day to network, exchange ideas and explore advances in R&D, manufacturing, data management, AI and innovative financing. In addition, the embedded Global Village provides international delegations a platform to strengthen their ties with the Swiss biotech hub to promote cross-border investments, public-private partnerships, R&D collaborations and the exchange of best practices.
Representatives from Venture Valuation and Biotechgate will participate in Swiss Biotech Day 2026
The LSX Nordic Congress is the leading partnering, strategy, and investment event serving the Nordic and Baltic region, with qualified 1:1 partnering at its core.
The conference gathers senior life science industry decision-makers from the region's most innovative biotech, medtech, and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs.
Together, they share best practices, forge partnerships, and discuss investment – to revolutionise healthcare.
Get 15% off registration with the code VVC15
Representatives from Venture Valuation and Biotechgate will participate in LSX Nordic Congress
The Pharma Partnering Summit specializes in organizing premier Business Development and Licensing Conferences for Senior Executives and Decision-makers in the life sciences industry. These events provide a platform to discover products and partners while exploring potential partnering opportunities that empower the development and commercialization of drugs, as well as advancing the pharma and biotech sectors in general.
Get 15% off registration with the code MP-15%
Representatives from Venture Valuation and Biotechgate will participate in Pharma Partnering EU Summit 2026
UK Biotech Day is an international premier event for life science leaders, innovators, investors and service providers. Our mission is to unite the UK’s vibrant biotech ecosystem, spanning world-class research, dynamic startups, big pharma, and visionary investors, to drive breakthrough partnerships. Join us to discover new opportunities, forge strategic alliances, and help shape the next era of biotech success in the UK and the world.
Get 15% off registration with the code MP-15%
Representatives from Venture Valuation and Biotechgate will participate in UK Biotech Day
2nd Annual Obesity & Metabolic Diseases Innovation Forum
Building on the success of the inaugural Obesity forums in San Francisco and Leipzig, we are pleased to introduce the 2nd Annual Obesity & Cardiometabolic Innovation Forum (#Sachs_OCIF), taking place at the Royal Sonesta New Orleans, on the 5th of June 2026. The event precedes the American Diabetes Association’s (ADA's) 2026 Scientific Sessions, with virtual meetings scheduled for the 16th - 17th of June.
Join global investors, biotech leaders, and clinical innovators at OCIF 2026 – the premier forum where next-generation cardiometabolic science meets market transformation. With the metabolic health sector projected to surpass $250 billion by 2030, OCIF delivers access to the forces reshaping the landscape through scientific breakthroughs, strategic alliances, and headline acquisitions, including Akero, 89 Bio, and Metsera.
RESI San Diego 2026 will take place on June 22 at the JULEP Venue San Diego during the Convention Week, followed by FOUR (4) days of virtual partnering on June 23-24, 29-30. Virtual partnering on the June 29-30 gives you a chance to extend your Convention-week partnering! This hybrid format combines the benefits of in-person networking with the flexibility of online interactions.
Representatives from Venture Valuation and Biotechgate will participate in RESI San Diego 2026
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.
Whether you work at a public pharmaceutical company, biotech startup, academia, non-profit organization, or government agency; or you work as a researcher, business development professional or investor, BIO is where you'll make valuable connections and build relationships.
Representatives from Venture Valuation and Biotechgate will participate in BIO 2026
Biotechgate Digital Partnering is a virtual conference designed to support the business development of Biotech, Medtech and Pharma companies. Join five days of digital partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings, along with informal networking events and workshops.
Now in its fourth year, Asia Bio Partnering Forum will unite over 650 innovators from major Asian markets with global life science leaders to foster dealmaking and collaboration across the region.
Representatives from Venture Valuation and Biotechgate will participate in Asia Bio Partnering Forum
RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partnering on September 25,28-29. This hybrid format combines the benefits of in-person networking with the flexibility of online interactions
Representatives from Venture Valuation and Biotechgate will participate in RESI Boston 2026
LSX USA Congress gathers leaders from the US biotech and pharma sectors to network, showcase innovations, and explore partnership opportunities. It offers a unique platform for CEOs, investors, and pharma executives to engage in meaningful discussions and collaborative sessions, shaping the future of healthcare technology.
Representatives from Venture Valuation and Biotechgate will participate in LSX USA Congress
BIOSPAIN is one of the largest biotech events organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings and companies participating. 30% of our delegates came from outside of Spain. Also, of the 287 exhibitors, 32% were international.
This year, BIOSPAIN will be held in Bilbao, one of the main biotech cluster in Spain and One of Spain’s most avant-garde cities.
The event will take place in Pavillion 2, Bilbao Exhibition Cente, located in Barakaldo, less then 20 minutes from downtown Bilbao, it is one of the most modern and largest trade-show complexes in Europe.
Representatives from Venture Valuation and Biotechgate will participate in BIOSPAIN 2026
Returning for its 26th Annual Edition, this established global bio-pharma industry event will address the key challenges and investment trends for 2026, with a strong focus on partnering, alliance management, and future prospects. Leading industry figures will contribute their insights through a series of panel discussions covering the broader market outlook, as well as innovation across different therapeutic sectors. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage, and public companies with leading investors, analysts, money managers, and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners.
Representatives from Venture Valuation and Biotechgate will participate in 26th Annual Biotech in Europe Forum
BioFuture is where relentless therapeutic pioneers, innovators, and investors gather to assess and shape the future of healthcare and digital health. Participate in candid, unfiltered discussions. At this year’s summit, we’ll explore the exciting mashup between rapidly evolving fields including biopharma, digital medicine, big data, AI, healthcare systems, payors, and more. The coming decade will dramatically accelerate the transformation of the healthcare ecosystem. Be part of the discussions that will shape and transform the future of healthcare.
Representatives from Venture Valuation and Biotechgate will participate in BioFuture 2026
Looking for companies outside of the Nordic countries?
Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.